mature dendritic cells

Mature dendritic cells are a form of antigen-presenting cell used in immunotherapy, particularly as a cellular product for cancer vaccines. They are generated by differentiating precursor cells (often monocytes) in vitro and then inducing maturation using specific cytokines or stimuli. Mature dendritic cells express high levels of major histocompatibility complex (MHC) molecules and co-stimulatory molecules such as CD80, CD86, and CD83, along with chemokine receptor CCR7. These features enable them to efficiently present antigens to T lymphocytes and prime robust adaptive immune responses. In clinical applications, patient-derived monocytes are differentiated into immature dendritic cells using cytokines like GM-CSF and IL-4; these are then matured with additional stimuli before being loaded with tumor antigens ex vivo and administered back to the patient as a personalized cancer vaccine[8][10]. The primary mechanism is the activation of antigen-specific T-cell immunity against tumors or pathogens.

Other names

dendritic cell vaccinemature DCs